Neuranics to Establish World-Leading Semiconductor Facility Backed by Glasgow's £160M Investment Zone
GLASGOW, Scotland--(BUSINESS WIRE)--Neuranics, a Glasgow-based innovator in ultra-sensitive magnetic sensing solutions, has been shortlisted as one of six projects to be supported through the £160 million Glasgow City Region Investment Zone.
Noel McKenna, CEO of Neuranics: 'This project will be a catalyst for economic growth, driving innovation in bio-signal monitoring and giving other companies and researchers access to world-class infrastructure, right here in Scotland.'
Share
Formally confirmed in the UK Government Spending Review, the Investment Zone aims to accelerate innovation in advanced manufacturing areas such as semiconductors. Neuranics' project, in partnership with Kelvin Nanotechnology (KNT) and the James Watt Nanofabrication Centre (JWNC) at the University of Glasgow, will create a new nanofabrication centre establishing world-leading manufacturing capability for magnetic sensor technology.
The facility will be the first in the UK dedicated to full end-to-end magnetic sensor fabrication and assembly, supported by advanced tools including one of only two Ion Beam Etch systems in the UK. The project will strengthen UK supply chains, enable faster product development and secure local ownership of high-value IP.
Neuranics' TMR sensors detect minute magnetic fields from the human body, enabling next-generation wearables, gesture interfaces and health monitoring tools. With strong global interest from major consumer electronics companies, bringing production to Glasgow will position the region as a world leader in sensor innovation.
Key project outcomes will include:
Over 100 skilled jobs over ten years in engineering, manufacturing and commercial roles
A major boost to Glasgow's advanced manufacturing infrastructure
Strengthened local supply chains across the Scottish tech ecosystem
Inclusive training pathways through apprenticeships and graduate roles
Increased collaboration with regional tech and academic partners
'We are delighted to have been shortlisted as part of the Glasgow City Region Investment Zone,' said Noel McKenna, CEO of Neuranics. 'This project will be a catalyst for economic growth, driving innovation in bio-signal monitoring and giving other companies and researchers access to world-class infrastructure, right here in Scotland.'
The project directly supports the aims of the Glasgow City Region Investment Zone, Scotland's National Strategy for Economic Transformation and the UK Government's Levelling Up agenda. It is expected to boost advanced manufacturing, support net-zero goals and widen access to high-growth tech careers.
About Neuranics
Neuranics, based in Scotland, is a pioneering company at the forefront of magnetic sensing solutions, redefining human-machine interaction. By integrating ultra-sensitive TMR technology with custom circuit design and advanced hardware and software, Neuranics develops transformative solutions for XR, next-generation human-machine interfaces, and wearable health monitoring.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Apella Wealth Expands National Presence with Addition of Iron Horse Wealth Management, Adding $574 Million in AUM
WEST HARTFORD, Conn.--(BUSINESS WIRE)--Apella Wealth ('Apella'), a financial advisory and wealth management firm serving individuals, families, and businesses, announced today that Iron Horse Wealth Management ('Iron Horse'), a registered investment adviser ('RIA'), has joined the firm. This partnership establishes Apella's presence in Johnston, IA, and extends the firm's financial planning and investment management services into the Midwest region. Led by Founder and President, Dennis Markway, Iron Horse is a fee-only advisory firm providing comprehensive financial planning and fiduciary guidance to individuals and families. The entire Iron Horse team will join Apella, and Dennis Markway will assume the role of Regional Director. 'We are thrilled to welcome Iron Horse to the Apella team,' said Patrick Sweeny, CEO of Apella. 'We share a commitment to personalized, fiduciary advice, and we look forward to celebrating our collective growth and success.' 'This partnership represents a significant milestone in Apella's geographic expansion as we establish our first Midwest-based team,' said Jim Scanlan, President of Apella. 'We are excited to welcome a highly respected firm, known for its unwavering commitment to clients, to Apella.' 'We are overjoyed to join Apella, a team that holds itself to the highest ethical and fiduciary standards and shares our deep dedication to clients, employees, and communities,' said Dennis Markway, Founder and President of Iron Horse. 'We are excited to collaborate, share expertise, and learn from our peers, knowing that together we can make a meaningful impact.' This marks Apella's 22 nd transaction, and 11 th since partnering with Wealth Partners Capital Group ('WPCG'), a financial services holding company that invested in Apella in September 2021. The transaction closed on June 20, 2025. As of closing, Apella has $6.08 billion in assets under management. About Apella Wealth Apella Wealth ('Apella'), founded in 2014 is a national RIA built around a select community of like-minded advisors who believe in Evidence-Based investing and detailed financial planning. Headquartered in West Hartford, CT, Apella offers a wide range of financial advisory services across multiple locations, spanning both coasts and serving thousands of individual and institutional investors. The firm's financial advisors are dedicated to building lifelong client relationships and providing 'Advice for Life.' For more information about Apella, please visit About Wealth Partners Capital Group Wealth Partners Capital Group ("WPCG") is a financial services holding company, which invests in and partners with select leading wealth management firms. WPCG assists its partner firms by identifying and integrating like-minded wealth advisers who seek access to expanded business capabilities, strategic growth and/or customized transition solutions. For more information, please visit Apella Wealth is an investment advisory firm registered with the Securities and Exchange Commission (SEC). The firm only transacts business in states where it is properly registered or excluded or exempted from registration requirements. Registration of an investment adviser does not imply any specific level of skill or training and does not constitute an endorsement of the firm by the SEC. The information here is provided for general information purposes only and should not be considered a recommendation or personalized investment advice.
Business Wire
an hour ago
- Business Wire
Trially AI Taps Serial Entrepreneur Christian Smith as CRO to Expand AI Clinical Trial Enrollment Across U.S.
KANSAS CITY, Mo.--(BUSINESS WIRE)-- Trially®, a breakthrough AI clinical trial recruitment technology to unlock faster qualified patient enrollment, today announced the appointment of as Chief Revenue Officer. A serial entrepreneur and proven operator, Smith brings a track record of scaling quality service for healthcare organizations and will lead efforts to accelerate trial enrollment for U.S. site networks, healthcare systems, and sponsors with Trially's AI tools. When my mom passed away of breast cancer in 2005, we had no clue there were 28 studies running within driving distance, including studies for Trastuzumab and Bevacizumab which represent some of the top treatments on the market today. Smith joins Trially at a pivotal moment. As clinical research sites face mounting enrollment pressure and shrinking pipelines, Trially has emerged as a category-defining technology. In a landscape where 68% of sites miss enrollment targets and screen failure rates continue to rise, Trially AI is enabling sites to predictably prescreen and qualify patients for trials — with or without an EHR integration — helping teams multiply enrollment for even the most complex protocols in record time. 'In my late teens, I found how difficult it is to navigate medical care when standard treatment paths do not yield results,' said Smith. 'When my mom passed away of breast cancer in 2005, we had no clue there were 28 studies running within driving distance, including studies for Trastuzumab and Bevacizumab which represent some of the top treatments on the market today. It is an honor to join Trially to serve the physician networks and sites by matching patients with novel drug therapies to improve health outcomes and the standard of care.' Prior to Trially, Smith co-founded TrackR, where he helped create the Bluetooth tracking category and grew revenue to over $50 million. During the COVID-19 pandemic, he led direct-to-consumer operations at Dascena, opening 44 testing sites across 26 cities. Most recently, he co-founded Forta, where he pioneered a family centric autism therapy model powered by AI. His expertise in direct-to-patient recruitment, AI-driven care models, and scaling operational quality — are critical to best support Trially partners. 'Christian brings the exact mindset we value at Trially: efficiency, transparency, empathy,' said Trevor Welch, Co-founder and Chief Product Officer of Trially. "He understands what it means to scale with purpose, and he's passionate about empowering research teams to help patients get access to life-saving therapies. His arrival marks a new chapter in our mission to unlock faster qualified patient enrollment across the industry.' About Trially Trially® is shaping the future of clinical trial recruitment with its proprietary AI matching technology that safely unlocks rich clinical data to enroll qualified patients faster. Proven to multiply enrollment rates by 200%, dramatically reduce screen failures and improve site efficiency, Trially's site-based software rapidly integrates with any EHR or CTMS system while maintaining full compliance with HIPAA, SOC 2, FDA 21 CFR Part 11 and ISO 27001 regulations. Designed to meet the needs of physicians, research sites and pharmaceutical sponsors, Trially empowers you to achieve outstanding results in clinical research. For more information visit
Business Wire
an hour ago
- Business Wire
Patrick Funke & Associates Chooses Commonwealth for Operational Ease and Efficiency
WALTHAM, Mass.--(BUSINESS WIRE)--Commonwealth Financial Network ®, a national RIA dedicated to providing financial advisors with holistic, integrated business solutions, welcomes Phoenix, Arizona-based Patrick Funke & Associates to its network of independent advisors. Advisor Patrick Funke, CLU ®, ChFC ®, AIF ®, manages the practice together with his wife and longtime business partner, Jennifer Funke. Previously with Osaic, the team reported advising on more than $430 million in client assets.* The Commonwealth model means partnering with a high-level, professional team that's relationship-focused, not transaction-oriented. Share 'Patrick and Jennifer sought an operational model that would free up time to focus on client service and growing their practice, and we're honored that they found their long-term fit with Commonwealth,' said Becca Hajjar, managing principal and chief business development officer. More than 25 years ago, Patrick Funke recognized an opportunity to build a sustainable niche serving small corporate retirement plans with a strong focus on participant education. 'Oftentimes, a workplace 401(k) meeting can be the first interaction an investor has with an advisor,' explained Funke. 'This provides an opportunity to make those meetings a gateway to making a genuine difference in people's lives.' The practice has grown entirely by word-of-mouth referrals. Its individual, family, and trust clients include business owners and others connected to its retirement plan business, among others. 'We aim to be a lower-cost provider, offering financial planning and investment services consistent with what I describe as an evidence-based approach to investment selection,' said Funke. Learn more about the practice at In selecting a partner firm, Jennifer Funke emphasized the need for efficiency, order, and intuitive technology. 'With the Commonwealth approach, we appreciate that when we have questions, people pick up the phone, listen, and call back promptly,' she said. Since the practice serves hundreds of clients, the Funkes were wary about the transition process but found it smooth. 'Now that we've transitioned, we're finding that opening a new account takes five minutes. The system generates all the forms, and it's easy for clients to approve via DocuSign.' 'I'm getting time back already,' said Patrick Funke. 'When we last changed our partner firm, it was for additional size and scale. That's not enough, though, because relationships are the lifeblood of our firm. The Commonwealth model means partnering with a high-level, professional team that's relationship-focused, not transaction-oriented. Looking ahead, Commonwealth and LPL will give us the foundation to grow our practice.' About Commonwealth Financial Network® Commonwealth Financial Network, Member FINRA/SIPC, a Registered Investment Adviser, provides financial advisors with holistic, integrated solutions that support business evolution, growth acceleration, and operational efficiency. J.D. Power ranks Commonwealth '#1 in Independent Advisor Satisfaction Among Financial Investment Firms, 11 Times in a Row.' Privately held since 1979, the firm has headquarters in Waltham, Massachusetts, and San Diego, California, and an operations hub in Blue Ash, Ohio. Learn more about how Commonwealth partners with approximately 2,345 independent financial advisors overseeing more than $344 billion** in assets nationwide by visiting Commonwealth received the highest score among independent advisors in the J.D. Power 2010, 2012–2014, and 2018‒2024 U.S. Financial Advisor Satisfaction Studies. Presented on July 10, 2024, for January to May of 2024, it is based on responses from 4,072 advisors employed by or affiliated with the firms included in the study. Not indicative of the firm's future performance. Your experience may vary. Study is independently conducted, and the participating firms do not pay to participate. Use of study results in promotional materials is subject to a license fee. Visit for more details. ** As of 12/31/2024
